Realta Life Sciences Inc.
- Address
- 5665 Lowery Road
Sponsor Overview
Specializations
Haematology and Transplantation
Realta Life Sciences Inc. focuses on acute graft-versus-host disease, a serious complication seen after allogeneic stem cell transplantation. Its clinical research is centered on hospital-based care for patients with steroid-refractory disease, with attention to immune-mediated tissue injury and post-transplant complications.
- Acute graft-versus-host disease
- Allogeneic stem cell transplantation
- Steroid-refractory disease
The sponsor’s research activity is concentrated in settings where immunological complications of transplantation require targeted therapeutic options.
Immunology and Inflammatory Disease
The sponsored trials examine treatment of immune dysregulation in aGvHD, with interest in controlling the inflammatory processes that drive acute organ damage. This places the sponsor within therapeutic areas related to immune modulation and inflammatory response.
- Immune dysregulation
- Immune modulation
- Inflammatory response
Clinical interest extends to evaluating therapeutic effects in patients with complex post-transplant immune complications.
Hospital Medicine and Acute Care
The research landscape includes hospitalized patients requiring specialist management of steroid-refractory aGvHD. This reflects an interest in acute inpatient treatment environments where rapid clinical assessment and response are central to care.
- Hospitalized patients
- Acute care
- Specialist inpatient management
The sponsor’s activity is aligned with therapeutic development for severe complications managed in transplant centres and related specialty hospital settings.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of RLS-0071 in Hospitalized Patients with Steroid-Refractory Acute Graft-versus-Host Disease: A Phase 2 Dose-Ranging Study |  Germany Spain | Not Yet Recruiting |
| Phase 2 Open‑Label Dose‑Ranging Study of RLS‑0071 in Hospitalized Patients with Steroid‑Refractory Acute Graft‑Versus‑Host Disease | Germany Spain | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 9 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune system processes2 trials65 other sponsors
Partnered Research Centres
9 centres- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Paseo De San Vicente 58-182, 37007 Salamanca
- Address
- Avenida Valdecilla Sn, 39008 Santander
- Address
- Avenida Fernando Abril Martorell 106, 46026 Valencia
- Address
- Hugstetter Strasse 55, Stuehlinger, 79106 Freiburg im Breisgau
- Address
- Von-Esmarch-Strasse 58, Sentrup, 48149 Munster
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Realta Life Sciences Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.